Torres J L, Haro I, Valencia G, Reig F, García-Antón J M
Peptide Research Section, Centre d'Investigació i Desenvolupament, C.S.I.C., Barcelona, Spain.
Experientia. 1989 Jun 15;45(6):574-6. doi: 10.1007/BF01990511.
A new series of O-glycosyl enkephalins has been prepared, following a convergent strategy, with high chemical yields. The galactosyl analogue, O1.5-(beta-D-galactopyranosyl) [DMet2, Hyp5] enkephalin amide proved to be one of the most potent in vivo opioid agonists synthesized up to now.